UB Paderborn / Katalog / Suche / in CDI

Dasatinib–Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults

The New England journal of medicine, 2020-10, Vol.383 (17), p.1613-1623

2020

Link zum Volltext

Verfügbarkeit prüfen

Epidemiology of Carbapenem Resistant Klebsiella pneumoniae Infections in Mediterranean Countries

Mediterranean journal of hematology and infectious diseases, 2016-07, Vol.8 (1), p.e2016032-e2016032

2016

Link zum Volltext

Verfügbarkeit prüfen

Chimeric Antigen Receptor T-Cell Therapy in Acute Myeloid Leukemia: State of the Art and Recent Advances

Cancers, 2023-12, Vol.16 (1), p.42

2023

Link zum Volltext

Verfügbarkeit prüfen

CPX-351: An Old Scheme with a New Formulation in the Treatment of High-Risk AML

Cancers, 2022-06, Vol.14 (12), p.2843

2022

Link zum Volltext

Verfügbarkeit prüfen

Response to Interferon-Free Direct Antivirals (DAAS) Treatment in HCV-Related Subcutaneous Lipoma-Like Marginal Zone B-Cell Lymphoma

Mediterranean journal of hematology and infectious diseases, 2019-08, Vol.11 (1), p.e2019053

2019

Link zum Volltext

Verfügbarkeit prüfen

A case of late isolated ovarian relapse of acute lymphoblastic leukemia after an allogeneic stem cell transplant

Leukemia & lymphoma, 2015-05, Vol.56 (5), p.1517-1520

2015

Link zum Volltext

Verfügbarkeit prüfen

Body mass index does not impact on molecular response rate of chronic myeloid leukaemia patients treated frontline with second generation tyrosine kinase inhibitors

British journal of haematology, 2018-08, Vol.182 (3), p.427-429

2018

Link zum Volltext

Verfügbarkeit prüfen

Complete remission obtained with azacitidine in a patient with concomitant therapy related myeloid neoplasm and pulmonary mucormycosis

Mediterranean journal of hematology and infectious diseases, 2013-01, Vol.5 (1), p.e2013048-e2013048

2013

Link zum Volltext

Verfügbarkeit prüfen

Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913

Haematologica (Roma), 2021-06, Vol.106 (6), p.1559-1568

2021

Link zum Volltext

Verfügbarkeit prüfen

Adolescent and young adult acute lymphoblastic leukemia. Final results of the phase II pediatric‐like GIMEMA LAL‐1308 trial

American journal of hematology, 2021-03, Vol.96 (3), p.292-301

2021

Link zum Volltext

Verfügbarkeit prüfen

Hairy cell leukaemia with low CD103 expression: A rare but important diagnostic pitfall

British journal of haematology, 2022-07, Vol.198 (2), p.e28-e31

2022

Link zum Volltext

Verfügbarkeit prüfen

Applicability of droplet digital polymerase chain reaction for minimal residual disease monitoring in Philadelphia‐positive acute lymphoblastic leukaemia

Hematological oncology, 2021-12, Vol.39 (5), p.680-686

2021

Link zum Volltext

Verfügbarkeit prüfen

ZNF384 rearrangement is the most frequent genetic lesion in adult PH-negative and Ph-like-negative B-other acute lymphoblastic leukemia. Biological and clinical findings

Leukemia & lymphoma, 2023-01, Vol.64 (2), p.483-486

2023

Link zum Volltext

Verfügbarkeit prüfen

Ara-C, Idarubicine and Gentuzumab Ozogamicin (AIM) as Salvage Treatment in Advanced Acute Myeloid Leukemia Patients

Mediterranean journal of hematology and infectious diseases, 2012-01, Vol.4 (1), p.e2012072-e2012072

2012

Link zum Volltext

Verfügbarkeit prüfen

The Validation of the BCR/ABL1-like Predictor across Laboratories Shows Reproducibility of Results

Blood, 2019-11, Vol.134 (Supplement_1), p.5211-5211

2019

Link zum Volltext

Verfügbarkeit prüfen

Dasatinib-Blinatumomab Combination for the Front-Line Treatment of Adult Ph+ ALL Patients. Updated Results of the Gimema LAL2116 D-Alba Trial

Blood, 2019-11, Vol.134 (Supplement_1), p.740-740

2019

Link zum Volltext

Verfügbarkeit prüfen

The Eutos long‐term survival score accurately predicts the risk of death in chronic myeloid leukaemia patients treated outside of clinical trials

American journal of hematology, 2017-12, Vol.92 (12), p.E661-E664

2017

Link zum Volltext

Verfügbarkeit prüfen

Thrombopoietin receptor agonists to control immune thrombocytopenia in patients with active lymphoma

British journal of haematology, 2019-09, Vol.186 (6), p.e217-e219

2019

Link zum Volltext

Verfügbarkeit prüfen

Nivolumab as a safe and effective treatment in an HIV patient with refractory Hodgkin lymphoma

Annals of hematology, 2019-06, Vol.98 (6), p.1505-1506

2019

Link zum Volltext

Verfügbarkeit prüfen

Long-term response to daratumumab in a patient with advanced immunoglobulin light-chain (AL) amyloidosis with organ damage

Annals of hematology, 2019-04, Vol.98 (4), p.1047-1048

2019

Link zum Volltext

Verfügbarkeit prüfen

Very late relapse in a patient with acute promyelocytic leukemia (APL) rescued with a chemotherapy-free protocol

Leukemia & lymphoma, 2017-04, Vol.58 (4), p.999-1001

2017

Link zum Volltext

Verfügbarkeit prüfen

Current and future therapeutic approaches for the treatment of follicular lymphoma

Expert review of anticancer therapy, 2018-09, Vol.18 (9), p.931-941

2018

Link zum Volltext

Verfügbarkeit prüfen

Response to Interferon-Free Direct Antivirals (DAAS) Treatment in Hcv-Related Subcutaneous Marginal Zone B-Cell Lymphoma with Lipoma-Like Presentation: Report of Two Cases

Mediterranean journal of hematology and infectious diseases, 2019-09, Vol.11 (1)

2019

Link zum Volltext

Verfügbarkeit prüfen

Clinical results according to age in patients with chronic myeloid leukemia receiving imatinib frontline: The younger, the later, the worse?

European journal of haematology, 2018-11, Vol.101 (5), p.578-584

2018

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Dasatinib–Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults

Epidemiology of Carbapenem Resistant Klebsiella pneumoniae Infections in Mediterranean Countries

Chimeric Antigen Receptor T-Cell Therapy in Acute Myeloid Leukemia: State of the Art and Recent Advances

CPX-351: An Old Scheme with a New Formulation in the Treatment of High-Risk AML

Response to Interferon-Free Direct Antivirals (DAAS) Treatment in HCV-Related Subcutaneous Lipoma-Like Marginal Zone B-Cell Lymphoma

A case of late isolated ovarian relapse of acute lymphoblastic leukemia after an allogeneic stem cell transplant

Body mass index does not impact on molecular response rate of chronic myeloid leukaemia patients treated frontline with second generation tyrosine kinase inhibitors

Complete remission obtained with azacitidine in a patient with concomitant therapy related myeloid neoplasm and pulmonary mucormycosis

Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913

Adolescent and young adult acute lymphoblastic leukemia. Final results of the phase II pediatric‐like GIMEMA LAL‐1308 trial

Hairy cell leukaemia with low CD103 expression: A rare but important diagnostic pitfall

Applicability of droplet digital polymerase chain reaction for minimal residual disease monitoring in Philadelphia‐positive acute lymphoblastic leukaemia

ZNF384 rearrangement is the most frequent genetic lesion in adult PH-negative and Ph-like-negative B-other acute lymphoblastic leukemia. Biological and clinical findings

Ara-C, Idarubicine and Gentuzumab Ozogamicin (AIM) as Salvage Treatment in Advanced Acute Myeloid Leukemia Patients

The Validation of the BCR/ABL1-like Predictor across Laboratories Shows Reproducibility of Results

Dasatinib-Blinatumomab Combination for the Front-Line Treatment of Adult Ph+ ALL Patients. Updated Results of the Gimema LAL2116 D-Alba Trial

The Eutos long‐term survival score accurately predicts the risk of death in chronic myeloid leukaemia patients treated outside of clinical trials

Thrombopoietin receptor agonists to control immune thrombocytopenia in patients with active lymphoma

Nivolumab as a safe and effective treatment in an HIV patient with refractory Hodgkin lymphoma

Long-term response to daratumumab in a patient with advanced immunoglobulin light-chain (AL) amyloidosis with organ damage

Very late relapse in a patient with acute promyelocytic leukemia (APL) rescued with a chemotherapy-free protocol

Phase II trial with sequential clofarabine and cyclophosphamide for refractory and relapsed philadelphia-negative adult acute lymphoblastic leukemia. Results of the GIMEMA LAL 1610 protocol

Current and future therapeutic approaches for the treatment of follicular lymphoma

Response to Interferon-Free Direct Antivirals (DAAS) Treatment in Hcv-Related Subcutaneous Marginal Zone B-Cell Lymphoma with Lipoma-Like Presentation: Report of Two Cases

Clinical results according to age in patients with chronic myeloid leukemia receiving imatinib frontline: The younger, the later, the worse?

Suchergebnisse filtern